The catch-up campaign aims to inoculate these children against measles, mumps, and rubella, diphtheria, tetanus, pertussis, hepatitis B, tuberculosis, polio, rotavirus and pneumonia.
Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback